Want to see CTNM full AI Analyst Report?

Contineum Therapeutics, Inc. Class A (CTNM) Revenue

222 Followers

Contineum Therapeutics, Inc. Class A Revenue

Contineum Therapeutics, Inc. Class A had a revenue of 0.00 in the quarter ending Mar 31, 2026, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2025, Contineum Therapeutics, Inc. Class A had annual revenue of 0.00 with ― growth.

Revenue (ttm)

0.00

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

Employees

Market Cap

$564.53M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	―	―
Dec 31, 2024	―	-50.00M	-100.00%
Dec 31, 2023	50.00M	―	+∞%
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―